ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs),
Category: Antigen
Antiretroviral drug not effective for viral suppression
Researchers conducted a randomized double-blind study of the effectiveness of an HIV vaccine and has found it to be ineffective
Heplisav-B for prevention of Hepatitis B
U.S. Food and Drug Administration (FDA) has approved Heplisav-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by
Cyltezo for chronic inflammatory diseases
Cyltezo is for the treatment of multiple chronic inflammatory diseases, including: moderate to severe active rheumatoid arthritis, moderate to severe
Nanoparticle vaccine can kill different types of cancer
Researchers at UT Medical Center has developed nanoparticle vaccine Immunotherapy that can kill different types of cancer. Nanoparticle vaccines provide
